Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

View All Documentation

1294207

USP

Glucosamine hydrochloride

United States Pharmacopeia (USP) Reference Standard

Sinónimos:

D-(+)-Glucosamine hydrochloride, 2-Amino-2-deoxy-D-glucose hydrochloride, Chitosamine hydrochloride

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C6H13NO5 · HCl
Número de CAS:
66-84-2
Peso molecular:
215.63
Beilstein:
4157370
Número MDL:
MFCD00135831
Código UNSPSC:
41116107
ID de la sustancia en PubChem:
329749944
NACRES:
NA.24

grado

pharmaceutical primary standard

familia API

glucosamine

fabricante / nombre comercial

USP

mp

190-194 °C (dec.) (lit.)

aplicaciones

pharmaceutical (small molecule)

formato

neat

cadena SMILES

Cl.N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O

InChI

1S/C6H13NO5.ClH/c7-3-5(10)4(9)2(1-8)12-6(3)11;/h2-6,8-11H,1,7H2;1H/t2-,3-,4-,5-,6?;/m1./s1

Clave InChI

QKPLRMLTKYXDST-NSEZLWDYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

Glucosamine hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Glucosamine and Chondroitin Sulfate Sodium Tablets
  • Glucosamine and Methylsulfonylmethane Tablets
  • Glucosamine Hydrochloride
  • Glucosamine Sulfate Potassium Chloride
  • Glucosamine Sulfate Sodium Chloride
  • Glucosamine Tablets
  • Glucosamine, Chondroitin Sulfate Sodium, and Methylsulfonylmethane Tablets

Acciones bioquímicas o fisiológicas

Glucosamine, an amino sugar, is the precursor of the hexosamine biosynthetic pathway leading to the formation of UDP-N-acetylglucosamine (UDP-GlcNAc), which is then used for making glycosaminoglycans, proteoglycans, and glycolipids. D-(+)-Glucosamine inhibits the coaggregation of Candida yeast species with the bacterial strain S. salivarius.

Nota de análisis

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Otras notas

Sales restrictions may apply.

Producto relacionado

Referencia del producto
Descripción
Precios

PHR1223

2-Methylpyrazine, Pharmaceutical Secondary Standard; Certified Reference Material

Y0001376

2-Methylpyrazine, European Pharmacopoeia (EP) Reference Standard

Y0001381

Glucosamine for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0001407

Glucosamine sulfate sodium chloride, European Pharmacopoeia (EP) Reference Standard

Y0001406

Glucosamine hydrochloride, European Pharmacopoeia (EP) Reference Standard

PHR1432

N-Acetil-D-glucosamina, Pharmaceutical Secondary Standard; Certified Reference Material

Y0001685

Glucosamine sulfate potassium chloride, European Pharmacopoeia (EP) Reference Standard

1010022

N-Acetil-D-glucosamina, United States Pharmacopeia (USP) Reference Standard

PHR2290

Glucosamine Impurity B, Pharmaceutical Secondary Standard; Certified Reference Standard

PHR2460

Glucosamine Impurity E, Pharmaceutical Secondary Standard; Certified Reference Material

Código de clase de almacenamiento

11 - Combustible Solids

Clase de riesgo para el agua (WGK)

WGK 3

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Oshra Betzer et al.
ACS nano, 8(9), 9274-9285 (2014-08-19)
A critical problem in the development and implementation of stem cell-based therapy is the lack of reliable, noninvasive means to image and trace the cells post-transplantation and evaluate their biodistribution, final fate, and functionality. In this study, we developed a
Antonella Denise Losinno et al.
Autophagy, 17(2), 439-456 (2020-01-28)
Cruzipain, the major cysteine protease of the pathogenic protozoa Trypanosoma cruzi, is an important virulence factor that plays a key role in the parasite nutrition, differentiation and host cell infection. Cruzipain is synthesized as a zymogen, matured, and delivered to
Ji-Sun Hwang et al.
Metabolism: clinical and experimental, 64(3), 368-379 (2014-12-18)
This study investigated the potential of glucosamine (GlcN) to affect body weight gain and insulin sensitivity in mice normal and at risk for developing diabetes. Male C57BL/6J mice were fed either chow diet (CD) or a high fat diet (HFD)
Khadijeh Jamialahmadi et al.
Environmental toxicology and pharmacology, 38(1), 212-219 (2014-06-25)
Glucosamine (GlcN) is an important precursor in the biochemical synthesis of glycosylated proteins and lipids in human body. It gains importance because of its contribution to human health and its multiple biological and therapeutic effects. In this study, the in
Viktor Chesnokov et al.
Cancer cell international, 14, 45-45 (2014-06-17)
We have reported that the glucosamine suppressed the proliferation of the human prostate carcinoma cell line DU145 through inhibition of STAT3 signaling. DU145 cells autonomously express IL-6 and the IL-6/STAT3 signaling is activated. IL-6 receptor subunits are subject to N-glycosylation
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico